Skip to content

OCT Evaluation of the Effects of Drug-Eluting Stent in Symptomatic Intracranial Vertebral Artery Stenosis

Follow-Up Optical Coherence Tomography (OCT) Evaluation of the Effects of Drug-Eluting Stent in Symptomatic Intracranial Vertebral Artery Stenosis: A Prospective, Single-center, Cohort Study

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116593
Enrollment
Unknown
Registered
2026-01-12
Start date
2026-01-12
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intracranial vertebral artery stenosis

Interventions

Case group:None

Sponsors

People's Hospital of Leshan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1.Age >=18 years, male or female; 2.Clinical and angiographic indication for intracranial vertebral artery stenosis (V4) >=50% with transient ischemic attack (TIA) or posterior circulation ischemia:; 3.Written informed consent.

Exclusion criteria

Exclusion criteria: 1.Known contraindication to DAPT treatment or endovascular intervention (i.e. major coagulation abnormalities, uncontrolled severe infections, severe systemic illnesses, uncontrolled hypertenshion); 2.Complicated with aneurysm, that cannot be treated earlier or at the same time or contraindication to surgery; 3. Gastrointestinal Diseases with active bleeding; 4.Myocardial infarction or major massive cerebral infarcts within 2 weeks; 5.Complicated with atrial fibrillation or history of anticoagulant; 6.Known hypersensitivity or contraindication to heparin, sirolimous, anaesthetic and contrast dye; 7.Bedridden or with other severe diseases; 8.Life expectancy less than 12 month; 9.According to the judgement of the investigator, other situations that are not suitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Any TIA, Stroke or all-caused Death Within 30 Days;

Secondary

MeasureTime frame
Cerebrovascular event;mRS ranking;Target lesion revascularization;NIH Stroke Scale;degree of stenosis;In-stent Restenosis or stent fracture;size, Calcification, fibrosis of Plaque;

Countries

China

Contacts

Public ContactBo Lei

People's Hospital of Leshan

08kaohx@163.com+86 133 5050 6972

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026